Yaky Yanay
2014
In 2014, Yaky Yanay earned a total compensation of $789.7K as Co, CEO and President at Pluristem Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Salary | $269,969 |
|---|---|
| Stock Awards | $492,000 |
| Other | $27,694 |
| Total | $789,663 |
Yanay received $492K in stock awards, accounting for 62% of the total pay in 2014.
Yanay also received $270K in salary and $27.7K in other compensation.
Rankings
In 2014, Yaky Yanay's compensation ranked 8,593rd out of 13,032 executives tracked by ExecPay. In other words, Yanay earned more than 34.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,593 out of 13,032 | 34th |
Division Manufacturing | 3,191 out of 4,966 | 36th |
Major group Chemicals And Allied Products | 1,082 out of 1,686 | 36th |
Industry group Drugs | 857 out of 1,365 | 37th |
Industry Biological Products, Except Diagnostic Substances | 152 out of 236 | 36th |
Source: SEC filing on March 30, 2017.
Yanay's colleagues
We found one more compensation record of an executive who worked with Yaky Yanay at Pluristem Therapeutics in 2014.
2014
Zami Aberman
Pluristem Therapeutics
Chief Executive Officer
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019